Staff and specialities
Professor : Toshihiro TANAKA
Bullous diseases
Associate Professor: Noriki FUJIMOTO
Collagen diseases, Skin surgery
Associate Professor: Takeshi NAKANISHI
Skin ulcer
Senior Lecturer: Takeshi KATO
Alopecia, Skin surgery
Assistant Professor: Kazuya TERAMURA
Skin surgery, Psoriasis
Assistant Professor: Junko NISHIKAWA
Assistant Professor: Takuma HAYAMI
Outline of the department
Outpatient clinics of the Dermatology of Department deal with over 20,000 patients per year with a variety of inflammatory and neoplastic skin diseases. Nineteen beds are available for inpatients. Over 400 patients per year hospitalize our clinic. Our general policy is to provide comfortable, patient-oriented medical care based upon well-balanced techniques between evidence-based medicine and narrative-based medicine. In this purpose, right of patients as well as duty of patients are important issues in our hospital. Standard therapy is our first choice in every field of skin diseases, including eczema, psoriasis, bullous disease, collagen disease, infectious disease, skin ulcer, disorder of keratinization and skin surgery.
Subjects of particular interest are listed above as subspeciality. Collagen diseases including systemic lupus erythematosus, dermatomyositis, systemic sclerosis, and adult Still’s disease, allergic skin diseases including atopic dermatitis and urticaria, metabolic diseases including psoriasis, skin ulcers and malignant skin diseases are treated with newly developed therapy using biologic treatments as well as standard protocols. We are also making efforts on dermatologic anti-aging therapy, which meets increasing patients' needs for more healthy and beautiful life. Early diagnosis and prevention of malignant skin diseases is another important subject of our department. Melanoma and non-melanoma skin cancers in early stages are curable by surgical resection combined with sentinel lymph node resection. Basic and clinical researches are conducted focusing upon dynamic relationship between environmental factors and physiological/immunological function of the skin. The outcome should be practical and useful to improve medical care. Current activities are concerned with pathological mechanism regarding regulatory B cells of collagen diseases and autoimmune bullous diseases, disease-specific gene polymorphism responsible for inflammatory diseases and hereditary diseases, better treatment protocols for skin ulcer especially for Buruli ulcer, and establishing clinical paths for prevention and surgical treatment of malignant skin diseases.
